Suppr超能文献

伽玛刀放射外科治疗库欣病患者:侵袭性垂体促肾上腺皮质细胞瘤与促肾上腺皮质腺瘤的比较。

Gamma knife radiosurgery in patients with Cushing's disease: Comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma.

机构信息

Acıbadem University School of Medicine, Department of Endocrinology, İstanbul, Turkey.

Acıbadem University School of Medicine, Department of Neurosurgery, İstanbul, Turkey.

出版信息

Clin Neurol Neurosurg. 2020 Oct;197:106151. doi: 10.1016/j.clineuro.2020.106151. Epub 2020 Aug 17.

Abstract

Aggressive pituitary corticotroph tumors causing Cushing's disease are rare, and there is limited data about their clinical management. Here, we aimed to report our long-term experience with gamma knife radiosurgery (GKRS) as adjuvant treatment in patients with residual or recurrent pituitary corticotroph tumors. This retrospective study included 45 adult patients (M/F, 7/38; mean age, 40.2 ± 13.1 years) with residual tumor or recurrence after initially successful surgical resection. Single-session GKRS was performed in all patients. Tumors with a Ki-67 value higher than 3 % and radiologic invasion to surrounding tissues were classified as aggressive tumor group. Clinical, hormonal and radiological findings were compared between the aggressive (n = 10) and non-aggressive adenoma (n = 35) groups. Following GKRS, tumor volumes were significantly reduced in both groups. The mean time to hormonal remission in the non-aggressive group was significantly shorter than in the aggressive group (23.5 ± 6.3 vs 33.0 ± 5.0 month, respectively, p < 0.05). New-onset hypopituitarism was identified in only seven patients (15 %) after GKRS in the whole cohort. The present study introduces several essential findings about aggressive corticotroph tumors. First, aggressive behavior tends to occur more frequently in male subjects. Second, time to GKRS was significantly shorter in the aggressive group. Moreover, a tumor volume ≥2 cm may be associated with clinical aggressiveness in corticotroph tumors. In conclusion, we suggest that early adjuvant GKRS is an effective treatment option in aggressive pituitary corticotroph tumors.

摘要

导致库欣病的侵袭性垂体促皮质细胞瘤较为罕见,关于其临床治疗的数据有限。本研究旨在报告我们使用伽玛刀放射外科(GKRS)作为辅助治疗残留或复发性垂体促皮质细胞瘤患者的长期经验。这项回顾性研究纳入了 45 例经初始成功手术切除后出现残留肿瘤或复发的成年患者(7/38 例,男/女;平均年龄 40.2±13.1 岁)。所有患者均行单次 GKRS。Ki-67 值高于 3%且影像学侵犯周围组织的肿瘤被归类为侵袭性肿瘤组。比较了侵袭性(n=10)和非侵袭性腺瘤(n=35)两组患者的临床、激素和影像学表现。GKRS 后,两组肿瘤体积均显著缩小。非侵袭性组的激素缓解中位时间明显短于侵袭性组(分别为 23.5±6.3 个月和 33.0±5.0 个月,p<0.05)。整个队列中,GKRS 后仅 7 例(15%)新出现垂体功能减退。本研究介绍了侵袭性促皮质细胞瘤的一些重要发现。首先,侵袭性行为在男性中更为常见。其次,侵袭性组接受 GKRS 的时间明显缩短。此外,肿瘤体积≥2cm 可能与促皮质细胞瘤的临床侵袭性相关。总之,我们建议早期辅助 GKRS 是侵袭性垂体促皮质细胞瘤的有效治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验